In recent developments, the Department of Health and Human Services (HHS) has decided to abandon its threat to withhold Medicare and Medicaid funding related to transgender care amidst significant public outcry. This decision comes alongside an ongoing national debate on youth gender-affirming care. Various government agencies, including the DOJ, HHS, FTC, and FDA, are currently embroiled in efforts to restrict access to these services. Notably, Illinois Governor J.B. Pritzker has signed a law protecting trans patients by removing testosterone from government monitoring programs. However, many hospitals have begun to pause services related to gender-affirming care, responding to evolving policies on youth gender dysphoria care. The discourse surrounding the rights of medically transitioning minors continues, raising questions about the burden of proof and the appropriateness of existing measures.